Rajesh Ramaswamy, Head of AI at Precede Biosciences
Vision AI Award · CDO Vision Boston 2026
Precede Biosciences

Attendee

Rajesh Ramaswamy

Head of AI at Precede Biosciences

1Rooms joined
0Sessions on stage
1Awards

On their agenda

Priorities, mapped against profiled leaders

Source: 734 CIO Vision leader profiles with at least one priority theme, from 742 leaders in the series. Share of those leaders in each theme; leaders may have multiple themes. Yellow marks Rajesh's saved themes.

In the room

Boston, 26 Jun 2026

See the full Boston room
Boston room · 26 Jun 2026
Boston · 26 Jun 2026
Boston room · 26 Jun 2026
Boston · 26 Jun 2026
Boston room · 26 Jun 2026
On film

Working on now

About

<p>Rajesh Ramaswamy is building the next generation of intelligent systems that transform how we understand, predict, and engineer complex systems across health, finance, and the physical world. His work focuses on turning traditionally empirical disciplines into continuously learning, AI-driven systems. Across startups, growth-stage companies, and global enterprises, he has led the development and deployment of AI systems that deliver measurable scientific, operational, and commercial impact.</p><p><br></p><p>He is currently Head of AI at Precede Biosciences, where he leads the strategy, development, and deployment of foundational AI systems for diagnostics and data products. His work is focused on transforming blood into a continuously updated representation of human biology, enabling earlier and more precise interventions, and ultimately a shift from reactive to adaptive healthcare. By combining multimodal data, machine learning, and scalable AI infrastructure, he is helping build systems capable of decoding complex diseases from wide variety of signals, including genomic and immune signals, in blood at population scale.</p><p><br></p><p>Previously, Rajesh was Senior Vice President and Founding Head of AI at Sail Biomedicines, where he led the design and deployment of the company’s AI system for generating a novel class of programmable medicines. His work advanced a shift in drug creation from a process driven by chance to one grounded in engineering, where outcomes can be systematically improved and accelerated. The AI platform he helped pioneer contributed to multiple programs, including an in vivo CAR-T program.</p><p><br></p><p>Earlier, Rajesh founded and built the Data Driven Innovation office at EMD Serono, the North American biopharma business of Merck KGaA. There, he established enterprise AI capabilities and applied machine learning across the organization, enabling more effective commercial strategies and contributing to billion+ dollar product launches in Neurology, Immunology, and Oncology.</p><p><br></p><p>Rajesh began his career in quantitative finance, where he developed machine learning systems operating at the scale of billions of options trades per day across global markets.</p><p><br></p><p>He holds a Ph.D. in Computer Science from ETH Zürich, Switzerland.</p>

Summarised from public LinkedIn activity ·

Same agenda, other rooms

173 leaders share three or more of Rajesh's priorities

Partner with CIO Vision

Reach leaders like Rajesh

Four or five partners per room, alongside 50–100 CIOs and enterprise AI leaders. Tell us who you want to meet.

See the audience